Back to Search Start Over

Role of adenosine A2A receptors in hot and cold cognition: Effects of single-dose istradefylline in healthy volunteers

Authors :
Roxanne W. Hook
Masanori Isobe
George Savulich
Jon E. Grant
Konstantinos Ioannidis
David Christmas
Barbara J. Sahakian
Trevor W. Robbins
Samuel R. Chamberlain
RS: CAPHRI - R2 - Creating Value-Based Health Care
International Health
Source :
European Neuropsychopharmacology, 71, 55-64. Elsevier
Publication Year :
2023

Abstract

The role of the adenosine neurochemical system in human cognition is under-studied, despite such receptors being distributed throughout the brain. The aim of this study was to shed light on the role of the adenosine A2A receptors in human cognition using single-dose istradefylline. Twenty healthy male participants, aged 19-49, received 20 mg istradefylline and placebo, in a randomized, double-blind, placebo-controlled cross-over design. Cognition was assessed us-ing computerized cognitive tests, covering both cold (non-emotional) and hot (emotion-laden) domains. Cardiovascular data were recorded serially. Cognitive effects of istradefylline were explored using repeated measures analysis of variance and paired t-tests as appropriate. On the EMOTICOM battery, there was a significant effect of istradefylline versus placebo on the Social Information Preference task ( t = 2.50, p = 0.02, d =-0.59), indicating that subjects on istradefylline interpreted social situations more positively. No other significant effects were observed on other cognitive tasks, nor in terms of cardiovascular measures (pulse and blood pressure). De-briefing indicated that blinding was successful, both for participants and the research team. Further exploration of the role of adenosine A2A receptors in emotional pro-cessing may be valuable, given that abnormalities in related cognitive functions are implicated in neuropsychiatric disorders. The role of adenosine systems in human cognition requires fur-ther clarification, including with different doses of istradefylline and over different schedules of administration.(c) 2023 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license ( http://creativecommons.org/licenses/by/4.0/ )

Details

Language :
English
ISSN :
0924977X
Volume :
71
Database :
OpenAIRE
Journal :
European Neuropsychopharmacology
Accession number :
edsair.doi.dedup.....ae569e428b0f5cf78b4322b8c6c0c59e